Interestingly, according to our results, HLA-E, HLA-DMA, HLA-DMB, HLA-DOA and HLA-DRB6 showed association with improved disease-free survival in both cohorts, emphasizing the need to investigate the functional implications of HLA expression in HCC using pre-clinical and clinical studies. This evidence concerns the gene HLA-DMB and hepatocellular carcinoma.